Answers are grounded in this paper and cite their sources.
tools for creating new AMPs and AMPs' conjugates and their clinical development are also discussed. Furthermore, key future considerations regarding the major achievements and challenges of AMPs' conjugates in the antimicrobial resistance context are presented as a take-home message.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: